Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Inhaled APN01 Developed as Treatment for COVID-19
Clinical trial NCT05065645 · COMPLETED
Trial details
- NCT number
- NCT05065645
- Sponsor
- Apeiron Biologics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-19
- Primary completion
- 2022-05-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.